Precision BioSciences Inc (DTIL)

3.81 -0.45 (-10.56%) USD  |  NASDAQ  |  Dec 31, 16:00
3.88 +0.07 (+1.84%) After-Hours: 20:00
More

Precision BioSciences Research and Development Expense (Annual): 53.38M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for DTIL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Pfizer Inc 10.68B
Assembly Biosciences Inc 48.90M
Protagonist Therapeutics Inc 120.16M
Alector Inc 192.12M
Entrada Therapeutics Inc 99.88M